ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
81 hedge funds and large institutions have $273M invested in Adamas Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $358K
Holders
81
Holding in Top 10
3
Calls
–
Puts
$358K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$8.08M | |
| 3 | +$2.64M | |
| 4 |
BWCA
Brenner West Capital Advisors
New York
|
+$2.5M |
| 5 |
NC
Nexthera Capital
New York
|
+$1.65M |
Top Sellers
| 1 | -$9.49M | |
| 2 | -$2.67M | |
| 3 | -$1.51M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.14M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$943K |